Cargando…

Comparison of the AmpFire(®) Multiplex HPV Assay to the Xpert(®) HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluation

Mostrar otras versiones (1)

BACKGROUND: Low- and middle-income countries (LMICs) account for nearly 85% of the global cervical cancer burden, yet have the least access to high-performance screening. International guidelines recommend human papillomavirus testing (HPV) as primary screening, yet implementation is inhibited by th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moyo, Sikhulile, Ramogola-Masire, Doreen, Moraka, Natasha, Tawe, Leabaneng, Noubary, Farzad, Motsumi, Kesego, Manowe, Godiraone, Zuze, Boitumelo, Radibe, Botshelo, Hungwe, Faith TT, Mohammed, Terence, Maphorisa, Comfort, Shapiro, Roger, Gaseitsiwe, Simani, Luckett, Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002806/ https://www.ncbi.nlm.nih.gov/pubmed/36909533 http://dx.doi.org/10.21203/rs.3.rs-2606441/v1

Ejemplares similares

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation
por: Moyo, Sikhulile, et al.
Publicado: (2023)

Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR
por: Tawe, Leabaneng, et al.
Publicado: (2018)

Detection of high-risk human papillomavirus (HPV) by the novel AmpFire isothermal HPV assay among pregnant women in Pemba Island, Tanzania
por: Juliana, Naomi Christine Angela, et al.
Publicado: (2020)

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay
por: Rantshabeng, Patricia, et al.
Publicado: (2019)

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results
por: Zhang, Yi, et al.
Publicado: (2023)

Comparison of AmpFire and MY09/11 assays for HPV genotyping in anogenital specimen of Rwandan men who have sex with men
por: Kanyabwisha, Faustin, et al.
Publicado: (2023)

Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana
por: Tawe, Leabaneng, et al.
Publicado: (2021)

Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya
por: Tawe, Leabaneng, et al.
Publicado: (2022)

Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2020)

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana
por: Mokaleng, Baitshepi, et al.
Publicado: (2023)

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
por: Maseng, Monkgomotsi J., et al.
Publicado: (2022)

Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana
por: Effah, Kofi, et al.
Publicado: (2023)

HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads
por: Bareng, Ontlametse T, et al.
Publicado: (2022)

Cervical human papillomavirus genotypes in a high HIV setting: A scoping review of a decade of human papillomavirus epidemiological research in Botswana
por: Tawe, Leabaneng, et al.
Publicado: (2022)

Identifying Recent HIV Infections: From Serological Assays to Genomics
por: Moyo, Sikhulile, et al.
Publicado: (2015)

A Cross-Sectional Study of HPV Vaccine Acceptability in Gaborone, Botswana
por: DiAngi, Yumi Taylor, et al.
Publicado: (2011)

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana
por: Maseng, Monkgomotsi J, et al.
Publicado: (2021)

Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping
por: Kim, Moonsik, et al.
Publicado: (2022)

Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer
por: Sobota, Rafal S, et al.
Publicado: (2014)

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana
por: Rantshabeng, Patricia S., et al.
Publicado: (2017)

HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring
por: McClung, Nancy, et al.
Publicado: (2022)

Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use
por: Maruapula, Dorcas, et al.
Publicado: (2023)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

Comparison of the Seeplex HPV4A ACE and the Cervista HPV assays for the detection of HPV in hybrid capture 2 positive media
por: Min, Kyung-Jin, et al.
Publicado: (2012)

A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections
por: Ma, Zhihai, et al.
Publicado: (2022)

Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media
por: Jang, Dan, et al.
Publicado: (2021)

Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology
por: Grover, Surbhi, et al.
Publicado: (2023)

PCR-RFLP assay as an option for primary HPV test
por: Golfetto, L., et al.
Publicado: (2018)

No Difference in Antibody Responses to Tetanus Vaccine Among HIV-Exposed and -Unexposed Infants in Botswana
por: Smith, Christiana, et al.
Publicado: (2017)

Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications
por: Ermel, Aaron, et al.
Publicado: (2016)

Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays
por: Halfon, Philippe, et al.
Publicado: (2013)

Detection of high-risk HPV in FFPE specimens of various tumours using the BD Onclarity™ HPV Assay
por: van der Geize, Robert, et al.
Publicado: (2022)

Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana
por: Moraka, Natasha Onalenna, et al.
Publicado: (2021)

Near‐complete genome of SARS‐CoV‐2 Delta variant of concern identified in a symptomatic dog (Canis lupus familiaris) in Botswana
por: Choga, Wonderful T., et al.
Publicado: (2023)

Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection
por: Kim, Jinhee, et al.
Publicado: (2022)

Cervical cancer screening in HIV-endemic countries: An urgent call for guideline change
por: Grover, Surbhi, et al.
Publicado: (2023)

Development and Validation of a HPV-32 Specific PCR Assay
por: Herrel, Nicholas R, et al.
Publicado: (2009)

Performance of the Xpert HPV assay in women attending for cervical screening
por: Cuzick, Jack, et al.
Publicado: (2015)

An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
por: Chan, Wai Sing, et al.
Publicado: (2020)

2572. Decreased T-Cell Response, but Appropriate Antibody Production to Tetanus Vaccine Among HIV-Exposed Uninfected Infants in Botswana
por: Smith, Christiana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nk35ghbqr7904q7hsq3f8j7trm